{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T10:53:04Z","timestamp":1778151184767,"version":"3.51.4"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2020,3,12]],"date-time":"2020-03-12T00:00:00Z","timestamp":1583971200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,3,12]],"date-time":"2020-03-12T00:00:00Z","timestamp":1583971200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["EH 367\/5-1"],"award-info":[{"award-number":["EH 367\/5-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["EH 367\/7-1"],"award-info":[{"award-number":["EH 367\/7-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["SFB 940\/2"],"award-info":[{"award-number":["SFB 940\/2"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019916","name":"Swiss Anorexia Nervosa Foundation","doi-asserted-by":"crossref","award":["-"],"award-info":[{"award-number":["-"]}],"id":[{"id":"10.13039\/501100019916","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Nutr"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n<jats:title>Purpose<\/jats:title>\n<jats:p>The gut\u2013brain axis could be a possible key factor in the pathophysiology of anorexia nervosa. The neuropeptide peptide YY<jats:sub>3\u201336<\/jats:sub>, secreted by endocrine L cells of the gastrointestinal tract, is a known regulator of appetite and food intake. The objective of this study was to investigate peptide YY<jats:sub>3\u201336<\/jats:sub> plasma concentrations at different stages of anorexia nervosa in a combined cross-sectional and longitudinal design to differentiate between effects of acute undernutrition and more enduring characteristics.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Methods<\/jats:title>\n<jats:p>We measured fasting plasma peptide YY<jats:sub>3\u201336<\/jats:sub> concentrations in young patients with acute anorexia nervosa (<jats:italic>n<\/jats:italic>\u2009=\u200947) and long-term recovered patients (<jats:italic>n<\/jats:italic>\u2009=\u200935) cross-sectionally in comparison to healthy control participants (<jats:italic>n<\/jats:italic>\u2009=\u200958), and longitudinally over the course of inpatient treatment. Physical activity was controlled as it may modulate peptide YY secretion.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Results<\/jats:title>\n<jats:p>There was no group difference in peptide YY<jats:sub>3\u201336<\/jats:sub> concentration among young acutely underweight anorexia nervosa patients, long-term recovered anorexia nervosa patients, and healthy control participants. Longitudinally, there was no change in peptide YY<jats:sub>3\u201336<\/jats:sub> concentration after short-term weight rehabilitation. For acute anorexia nervosa patients at admission to treatment, there was a negative correlation between peptide YY<jats:sub>3\u201336<\/jats:sub> concentration and body mass index.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Conclusions<\/jats:title>\n<jats:p>The current study provides additional evidence for a normal basal PYY<jats:sub>3\u201336<\/jats:sub> concentration in AN. Future studies should study multiple appetite-regulating peptides and their complex interplay and also use research designs including a food challenge.<\/jats:p>\n<\/jats:sec>","DOI":"10.1007\/s00394-020-02210-7","type":"journal-article","created":{"date-parts":[[2020,3,12]],"date-time":"2020-03-12T20:02:32Z","timestamp":1584043352000},"page":"3791-3799","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Peptide YY3\u201336 concentration in acute- and long-term recovered anorexia nervosa"],"prefix":"10.1007","volume":"59","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8333-867X","authenticated-orcid":false,"given":"Friederike I.","family":"Tam","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8995-6401","authenticated-orcid":false,"given":"Maria","family":"Seidel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0194-7557","authenticated-orcid":false,"given":"Ilka","family":"Boehm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3341-7166","authenticated-orcid":false,"given":"Franziska","family":"Ritschel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5413-0359","authenticated-orcid":false,"given":"Klaas","family":"Bahnsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0820-8231","authenticated-orcid":false,"given":"Ronald","family":"Biemann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1109-7990","authenticated-orcid":false,"given":"Kerstin","family":"Weidner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1873-7081","authenticated-orcid":false,"given":"Veit","family":"Roessner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2132-4445","authenticated-orcid":false,"given":"Stefan","family":"Ehrlich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,3,12]]},"reference":[{"key":"2210_CR1","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1176\/appi.ajp.159.8.1284","volume":"159","author":"H-C Steinhausen","year":"2002","unstructured":"Steinhausen H-C (2002) The outcome of anorexia nervosa in the 20th century. Am J Psychiatry 159:1284\u20131293. https:\/\/doi.org\/10.1176\/appi.ajp.159.8.1284","journal-title":"Am J Psychiatry"},{"key":"2210_CR2","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.npep.2012.08.005","volume":"46","author":"P Holzer","year":"2012","unstructured":"Holzer P, Reichmann F, Farzi A (2012) Neuropeptide Y, peptide YY and pancreatic polypeptide in the gut\u2013brain axis. Neuropeptides 46:261\u2013274. https:\/\/doi.org\/10.1016\/j.npep.2012.08.005","journal-title":"Neuropeptides"},{"key":"2210_CR3","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1016\/0016-5085(85)90442-1","volume":"89","author":"TE Adrian","year":"1985","unstructured":"Adrian TE, Savage AP, Sagor GR, Allen JM, Bacarese-Hamilton AJ, Tatemoto K, Polak JM, Bloom SR (1985) Effect of peptide YY on gastric, pancreatic, and biliary function in humans. Gastroenterology 89:494\u2013499","journal-title":"Gastroenterology"},{"key":"2210_CR4","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1136\/gut.28.2.166","volume":"28","author":"AP Savage","year":"1987","unstructured":"Savage AP, Adrian TE, Carolan G, Chatterjee VK, Bloom SR (1987) Effects of peptide YY (PYY) on mouth to caecum intestinal transit time and on the rate of gastric emptying in healthy volunteers. Gut 28:166\u2013170","journal-title":"Gut"},{"key":"2210_CR5","doi-asserted-by":"publisher","first-page":"501","DOI":"10.3109\/00365529409092462","volume":"29","author":"A Wettergren","year":"1994","unstructured":"Wettergren A, Petersen H, Orskov C, Christiansen J, Sheikh SP, Holst JJ (1994) Glucagon-like peptide-1 7\u201336 amide and peptide YY from the L-cell of the ileal mucosa are potent inhibitors of vagally induced gastric acid secretion in man. Scand J Gastroenterol 29:501\u2013505","journal-title":"Scand J Gastroenterol"},{"key":"2210_CR6","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/S0196-9781(01)00611-8","volume":"23","author":"H Yang","year":"2002","unstructured":"Yang H (2002) Central and peripheral regulation of gastric acid secretion by peptide YY. Peptides 23:349\u2013358","journal-title":"Peptides"},{"key":"2210_CR7","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1146\/annurev-physiol-021113-170404","volume":"76","author":"S Manning","year":"2014","unstructured":"Manning S, Batterham RL (2014) The role of gut hormone peptide YY in energy and glucose homeostasis: twelve years on. Annu Rev Physiol 76:585\u2013608. https:\/\/doi.org\/10.1146\/annurev-physiol-021113-170404","journal-title":"Annu Rev Physiol"},{"key":"2210_CR8","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/j.coph.2004.06.007","volume":"4","author":"BMC McGowan","year":"2004","unstructured":"McGowan BMC, Bloom SR (2004) Peptide YY and appetite control. Curr Opin Pharmacol 4:583\u2013588. https:\/\/doi.org\/10.1016\/j.coph.2004.06.007","journal-title":"Curr Opin Pharmacol"},{"key":"2210_CR9","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1097\/MED.0b013e3282f3f4b1","volume":"15","author":"K Chandarana","year":"2008","unstructured":"Chandarana K, Batterham R (2008) Peptide YY. Curr Opin Endocrinol Diabetes Obes 15:65\u201372. https:\/\/doi.org\/10.1097\/MED.0b013e3282f3f4b1","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"2210_CR10","doi-asserted-by":"publisher","first-page":"E604","DOI":"10.1152\/ajpendo.00153.2007","volume":"293","author":"B Sloth","year":"2007","unstructured":"Sloth B, Davidsen L, Holst JJ, Flint A, Astrup A (2007) Effect of subcutaneous injections of PYY1\u201336 and PYY3\u201336 on appetite, ad libitum energy intake, and plasma free fatty acid concentration in obese males. Am J Physiol Endocrinol Metab 293:E604\u2013609. https:\/\/doi.org\/10.1152\/ajpendo.00153.2007","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"2210_CR11","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.molmet.2013.03.001","volume":"2","author":"K Chandarana","year":"2013","unstructured":"Chandarana K, Gelegen C, Irvine EE, Choudhury AI, Amouyal C, Andreelli F, Withers DJ, Batterham RL (2013) Peripheral activation of the Y2-receptor promotes secretion of GLP-1 and improves glucose tolerance. Mol Metab 2:142\u2013152. https:\/\/doi.org\/10.1016\/j.molmet.2013.03.001","journal-title":"Mol Metab"},{"key":"2210_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.mce.2018.10.018","author":"LA Berner","year":"2018","unstructured":"Berner LA, Brown TA, Lavender JM, Lopez E, Wierenga CE, Kaye WH (2018) Neuroendocrinology of reward in anorexia nervosa and bulimia nervosa: beyond leptin and ghrelin. Mol Cell Endocrinol. https:\/\/doi.org\/10.1016\/j.mce.2018.10.018","journal-title":"Mol Cell Endocrinol"},{"key":"2210_CR13","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1038\/nature00887","volume":"418","author":"RL Batterham","year":"2002","unstructured":"Batterham RL, Cowley MA, Small CJ, Herzog H, Cohen MA, Dakin CL, Wren AM, Brynes AE, Low MJ, Ghatei MA, Cone RD, Bloom SR (2002) Gut hormone PYY3-36 physiologically inhibits food intake. Nature 418:650\u2013654. https:\/\/doi.org\/10.1038\/nature00887","journal-title":"Nature"},{"key":"2210_CR14","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1038\/nature06212","volume":"450","author":"RL Batterham","year":"2007","unstructured":"Batterham RL, ffytche DH, Rosenthal JM, Zelaya FO, Barker GJ, Withers DJ, Williams SCR (2007) PYY modulation of cortical and hypothalamic brain areas predicts feeding behaviour in humans. Nature 450:106\u2013109. https:\/\/doi.org\/10.1038\/nature06212","journal-title":"Nature"},{"key":"2210_CR15","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1016\/j.cmet.2011.09.010","volume":"14","author":"A De Silva","year":"2011","unstructured":"De Silva A, Salem V, Long CJ, Makwana A, Newbould RD, Rabiner EA, Ghatei MA, Bloom SR, Matthews PM, Beaver JD, Dhillo WS (2011) The gut hormones PYY3-36 and GLP-17-36 amide reduce food intake and modulate brain activity in appetite centers in humans. Cell Metab 14:700\u2013706. https:\/\/doi.org\/10.1016\/j.cmet.2011.09.010","journal-title":"Cell Metab"},{"key":"2210_CR16","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1007\/s12020-015-0684-9","volume":"51","author":"F Fern\u00e1ndez-Aranda","year":"2016","unstructured":"Fern\u00e1ndez-Aranda F, Ag\u00fcera Z, Fern\u00e1ndez-Garc\u00eda JC, Garrido-Sanchez L, Alcaide-Torres J, Tinahones FJ, Giner-Bartolom\u00e9 C, Ba\u00f1os RM, Botella C, Cebolla A, de la Torre R, Fern\u00e1ndez-Real JM, Ortega FJ, Fr\u00fchbeck G, G\u00f3mez-Ambrosi J, Granero R, Islam MA, Jim\u00e9nez-Murcia S, T\u00e1rrega S, Mench\u00f3n JM, Fagundo AB, Sancho C, Estivill X, Treasure J, Casanueva FF (2016) Smell\u2013taste dysfunctions in extreme weight\/eating conditions: analysis of hormonal and psychological interactions. Endocrine 51:256\u2013267. https:\/\/doi.org\/10.1007\/s12020-015-0684-9","journal-title":"Endocrine"},{"key":"2210_CR17","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1093\/ajcn\/85.4.967","volume":"85","author":"N Germain","year":"2007","unstructured":"Germain N, Galusca B, Le Roux CW, Bossu C, Ghatei MA, Lang F, Bloom SR, Estour B (2007) Constitutional thinness and lean anorexia nervosa display opposite concentrations of peptide YY, glucagon-like peptide 1, ghrelin, and leptin. Am J Clin Nutr 85:967\u2013971. https:\/\/doi.org\/10.1093\/ajcn\/85.4.967","journal-title":"Am J Clin Nutr"},{"key":"2210_CR18","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.appet.2006.06.008","volume":"48","author":"B Otto","year":"2007","unstructured":"Otto B, Cuntz U, Otto C, Heldwein W, Riepl RL, Tsch\u00f6p MH (2007) Peptide YY release in anorectic patients after liquid meal. Appetite 48:301\u2013304. https:\/\/doi.org\/10.1016\/j.appet.2006.06.008","journal-title":"Appetite"},{"key":"2210_CR19","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/1743-7075-9-52","volume":"9","author":"D Sedlackova","year":"2012","unstructured":"Sedlackova D, Kopeckova J, Papezova H, Hainer V, Kvasnickova H, Hill M, Nedvidkova J (2012) Comparison of a high-carbohydrate and high-protein breakfast effect on plasma ghrelin, obestatin, NPY and PYY levels in women with anorexia and bulimia nervosa. Nutr Metab 9:52. https:\/\/doi.org\/10.1186\/1743-7075-9-52","journal-title":"Nutr Metab"},{"key":"2210_CR20","doi-asserted-by":"publisher","first-page":"2161","DOI":"10.1210\/jc.2004-1251","volume":"90","author":"S Stock","year":"2005","unstructured":"Stock S, Leichner P, Wong ACK, Ghatei MA, Kieffer TJ, Bloom SR, Chanoine JP (2005) Ghrelin, peptide YY, glucose-dependent insulinotropic polypeptide, and hunger responses to a mixed meal in anorexic, obese, and control female adolescents. J Clin Endocrinol Metab 90:2161\u20132168. https:\/\/doi.org\/10.1210\/jc.2004-1251","journal-title":"J Clin Endocrinol Metab"},{"key":"2210_CR21","doi-asserted-by":"publisher","first-page":"19","DOI":"10.4088\/JCP.13m08753","volume":"76","author":"KT Eddy","year":"2015","unstructured":"Eddy KT, Lawson EA, Meade C, Meenaghan E, Horton SE, Misra M, Klibanski A, Miller KK (2015) Appetite regulatory hormones in women with anorexia nervosa: binge-eating\/purging versus restricting type. J Clin Psychiatry 76:19\u201324. https:\/\/doi.org\/10.4088\/JCP.13m08753","journal-title":"J Clin Psychiatry"},{"key":"2210_CR22","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1210\/jc.2007-2419","volume":"93","author":"M Misra","year":"2008","unstructured":"Misra M, Prabhakaran R, Miller KK, Goldstein MA, Mickley D, Clauss L, Lockhart P, Cord J, Herzog DB, Katzman DK, Klibanski A (2008) Prognostic indicators of changes in bone density measures in adolescent girls with anorexia nervosa-II. J Clin Endocrinol Metab 93:1292\u20131297. https:\/\/doi.org\/10.1210\/jc.2007-2419","journal-title":"J Clin Endocrinol Metab"},{"key":"2210_CR23","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1210\/jc.2005-1878","volume":"91","author":"M Misra","year":"2006","unstructured":"Misra M, Miller KK, Tsai P, Gallagher K, Lin A, Lee N, Herzog DB, Klibanski A (2006) Elevated peptide YY levels in adolescent girls with anorexia nervosa. J Clin Endocrinol Metab 91:1027\u20131033. https:\/\/doi.org\/10.1210\/jc.2005-1878","journal-title":"J Clin Endocrinol Metab"},{"key":"2210_CR24","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1016\/j.jpsychires.2006.07.021","volume":"41","author":"T Nakahara","year":"2007","unstructured":"Nakahara T, Kojima S, Tanaka M, Yasuhara D, Harada T, Sagiyama K, Muranaga T, Nagai N, Nakazato M, Nozoe S, Naruo T, Inui A (2007) Incomplete restoration of the secretion of ghrelin and PYY compared to insulin after food ingestion following weight gain in anorexia nervosa. J Psychiatr Res 41:814\u2013820. https:\/\/doi.org\/10.1016\/j.jpsychires.2006.07.021","journal-title":"J Psychiatr Res"},{"key":"2210_CR25","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1210\/jc.2006-1425","volume":"92","author":"PT Pfluger","year":"2007","unstructured":"Pfluger PT, Kampe J, Castaneda TR, Vahl T, D\u2019Alessio DA, Kruthaupt T, Benoit SC, Cuntz U, Rochlitz HJ, Moehlig M, Pfeiffer AFH, Koebnick C, Weickert MO, Otto B, Spranger J, Tsch\u00f6p MH (2007) Effect of human body weight changes on circulating levels of peptide YY and peptide YY3-36. J Clin Endocrinol Metab 92:583\u2013588. https:\/\/doi.org\/10.1210\/jc.2006-1425","journal-title":"J Clin Endocrinol Metab"},{"key":"2210_CR26","doi-asserted-by":"publisher","first-page":"730409","DOI":"10.1155\/2012\/730409","volume":"2012","author":"DE Larson-Meyer","year":"2012","unstructured":"Larson-Meyer DE, Palm S, Bansal A, Austin KJ, Hart AM, Alexander BM (2012) Influence of running and walking on hormonal regulators of appetite in women. J Obes 2012:730409. https:\/\/doi.org\/10.1155\/2012\/730409","journal-title":"J Obes"},{"key":"2210_CR27","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.appet.2013.01.017","volume":"66","author":"H Kawano","year":"2013","unstructured":"Kawano H, Mineta M, Asaka M, Miyashita M, Numao S, Gando Y, Ando T, Sakamoto S, Higuchi M (2013) Effects of different modes of exercise on appetite and appetite-regulating hormones. Appetite 66:26\u201333. https:\/\/doi.org\/10.1016\/j.appet.2013.01.017","journal-title":"Appetite"},{"key":"2210_CR28","doi-asserted-by":"publisher","first-page":"R29","DOI":"10.1152\/ajpregu.90706.2008","volume":"296","author":"DR Broom","year":"2009","unstructured":"Broom DR, Batterham RL, King JA, Stensel DJ (2009) Influence of resistance and aerobic exercise on hunger, circulating levels of acylated ghrelin, and peptide YY in healthy males. Am J Physiol Regul Integr Comp Physiol 296:R29\u201335. https:\/\/doi.org\/10.1152\/ajpregu.90706.2008","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"2210_CR29","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/S0031-9384(03)00102-1","volume":"79","author":"J Hebebrand","year":"2003","unstructured":"Hebebrand J, Exner C, Hebebrand K, Holtkamp C, Casper RC, Remschmidt H, Herpertz-Dahlmann B, Klingenspor M (2003) Hyperactivity in patients with anorexia nervosa and in semistarved rats: evidence for a pivotal role of hypoleptinemia. Physiol Behav 79:25\u201337. https:\/\/doi.org\/10.1016\/S0031-9384(03)00102-1","journal-title":"Physiol Behav"},{"key":"2210_CR30","doi-asserted-by":"publisher","first-page":"3057","DOI":"10.1210\/jc.2009-2196","volume":"95","author":"N Germain","year":"2010","unstructured":"Germain N, Galusca B, Grouselle D, Frere D, Billard S, Epelbaum J, Estour B (2010) Ghrelin and obestatin circadian levels differentiate bingeing-purging from restrictive anorexia nervosa. J Clin Endocrinol Metab 95:3057\u20133062. https:\/\/doi.org\/10.1210\/jc.2009-2196","journal-title":"J Clin Endocrinol Metab"},{"key":"2210_CR31","volume-title":"Strukturiertes Inventar f\u00fcr anorektische und bulimische Essst\u00f6rungen (SIAB); Fragebogen (SIAB-S) und Interview (SIAB-EX) nach DSM-IV und ICD-10; Handanweisung","author":"M Fichter","year":"1999","unstructured":"Fichter M, Quadflieg N (1999) Strukturiertes Inventar f\u00fcr anorektische und bulimische Essst\u00f6rungen (SIAB); Fragebogen (SIAB-S) und Interview (SIAB-EX) nach DSM-IV und ICD-10; Handanweisung. Hogrefe, G\u00f6ttingen"},{"key":"2210_CR32","first-page":"365","volume":"47","author":"A Thiel","year":"1997","unstructured":"Thiel A, Jacobi C, Horstmann S, Paul T, Nutzinger DO, Sch\u00fc\u00dfler G (1997) Eine deutschsprachige Version des Eating Disorder Inventory EDI-2. [German translation of the Eating Disorder Inventory EDI-2.]. PPmP Psychother Psychosom Med Psychol 47:365\u2013376","journal-title":"PPmP Psychother Psychosom Med Psychol"},{"key":"2210_CR33","volume-title":"Beck Depressions-Inventar (BDI-II)","author":"M Hautzinger","year":"2009","unstructured":"Hautzinger M, K\u00fchner C, Keller F (2009) Beck Depressions-Inventar (BDI-II). Pearson Assessment and Information GmbH, Frankfurt"},{"key":"2210_CR34","volume-title":"Symptom-Checkliste von LR Derogatis: SCL-90-R; deutsche Version","author":"G Franke","year":"2002","unstructured":"Franke G, Derogatis L (2002) Symptom-Checkliste von LR Derogatis: SCL-90-R; deutsche Version. Beltz Test, G\u00f6ttingen"},{"key":"2210_CR35","doi-asserted-by":"publisher","first-page":"5169","DOI":"10.1210\/jc.2003-030569","volume":"88","author":"K Holtkamp","year":"2003","unstructured":"Holtkamp K, Herpertz-Dahlmann B, Mika C, Heer M, Heussen N, Fichter M, Herpertz S, Senf W, Blum WF, Schweiger U, Warnke A, Ballauff A, Remschmidt H, Hebebrand J (2003) Elevated physical activity and low leptin levels co-occur in patients with anorexia nervosa. J Clin Endocrinol Metab 88:5169\u20135174. https:\/\/doi.org\/10.1210\/jc.2003-030569","journal-title":"J Clin Endocrinol Metab"},{"key":"2210_CR36","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1016\/j.pnpbp.2009.03.007","volume":"33","author":"S Ehrlich","year":"2009","unstructured":"Ehrlich S, Burghardt R, Schneider N, Broecker-Preuss M, Weiss D, Merle JV, Craciun EM, Pfeiffer E, Mann K, Lehmkuhl U, Hebebrand J (2009) The role of leptin and cortisol in hyperactivity in patients with acute and weight-recovered anorexia nervosa. Prog Neuropsychopharmacol Biol Psychiatry 33:658\u2013662. https:\/\/doi.org\/10.1016\/j.pnpbp.2009.03.007","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"2210_CR37","volume-title":"WIE - Wechsler Intelligenztest f\u00fcr Erwachsene","author":"M von Aster","year":"2006","unstructured":"von Aster M, Neubauer A, Horn R (2006) WIE - Wechsler Intelligenztest f\u00fcr Erwachsene. Huber, Bern, Switzerland"},{"key":"2210_CR38","unstructured":"Petermann F, Petermann U (2010) HAWIK IV. Hamburg-Wechsler-Intelligenztest f\u00fcr Kinder IV. \u00dcbersetzung und Adaptation der WISC-IV von David Wechsler. Hogrefe, G\u00f6ttingen, Germany"},{"key":"2210_CR39","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","volume":"42","author":"PA Harris","year":"2009","unstructured":"Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG (2009) Research electronic data capture (REDCap)\u2014a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inf 42:377\u2013381. https:\/\/doi.org\/10.1016\/j.jbi.2008.08.010","journal-title":"J Biomed Inf"},{"key":"2210_CR40","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","volume":"57","author":"Y Benjamini","year":"1995","unstructured":"Benjamini Y, Hochberg Y (1995) Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc B Met 57:289\u2013300. https:\/\/doi.org\/10.1111\/j.2517-6161.1995.tb02031.x","journal-title":"J R Stat Soc B Met"},{"key":"2210_CR41","unstructured":"JASP Team (2019) JASP (Version 0.11.1) [Computer software]"},{"key":"2210_CR42","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1530\/EJE-10-0523","volume":"164","author":"EA Lawson","year":"2011","unstructured":"Lawson EA, Eddy KT, Donoho D, Misra M, Miller KK, Meenaghan E, Lydecker J, Herzog D, Klibanski A (2011) Appetite-regulating hormones cortisol and peptide YY are associated with disordered eating psychopathology, independent of body mass index. Eur J Endocrinol 164:253\u2013261. https:\/\/doi.org\/10.1530\/EJE-10-0523","journal-title":"Eur J Endocrinol"},{"key":"2210_CR43","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1530\/EJE-11-0312","volume":"165","author":"AE Rigamonti","year":"2011","unstructured":"Rigamonti AE, Cella SG, Bonomo SM, Mancia G, Grassi G, Perotti M, Agosti F, Sartorio A, M\u00fcller EE, Pincelli AI (2011) Effect of somatostatin infusion on peptide YY secretion: studies in the acute and recovery phase of anorexia nervosa and in obesity. Eur J Endocrinol 165:421\u2013427. https:\/\/doi.org\/10.1530\/EJE-11-0312","journal-title":"Eur J Endocrinol"},{"key":"2210_CR44","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/S0006-3223(98)00292-3","volume":"46","author":"KA Gendall","year":"1999","unstructured":"Gendall KA, Kaye WH, Altemus M, McConaha CW, La Via MC (1999) Leptin, neuropeptide Y, and peptide YY in long-term recovered eating disorder patients. Biol Psychiatry 46:292\u2013299. https:\/\/doi.org\/10.1016\/S0006-3223(98)00292-3","journal-title":"Biol Psychiatry"},{"key":"2210_CR45","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.bone.2008.03.007","volume":"43","author":"AL Utz","year":"2008","unstructured":"Utz AL, Lawson EA, Misra M, Mickley D, Gleysteen S, Herzog DB, Klibanski A, Miller KK (2008) Peptide YY (PYY) levels and bone mineral density (BMD) in women with anorexia nervosa. Bone 43:135\u2013139. https:\/\/doi.org\/10.1016\/j.bone.2008.03.007","journal-title":"Bone"}],"container-title":["European Journal of Nutrition"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00394-020-02210-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00394-020-02210-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00394-020-02210-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,12]],"date-time":"2021-03-12T00:33:13Z","timestamp":1615509193000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00394-020-02210-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,12]]},"references-count":45,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["2210"],"URL":"https:\/\/doi.org\/10.1007\/s00394-020-02210-7","relation":{},"ISSN":["1436-6207","1436-6215"],"issn-type":[{"value":"1436-6207","type":"print"},{"value":"1436-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,12]]},"assertion":[{"value":"12 February 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 February 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 March 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"VR has received payment for consulting and writing activities from Lilly, Novartis, and Shire Pharmaceuticals; lecture honoraria from Lilly, Novartis, Shire Pharmaceuticals, and Medice Pharma; and support for research from Shire and Novartis. He has carried out (and is currently carrying out) clinical trials in cooperation with Novartis, Shire, and Otsuka. VR has no financial relationship with the organizations that sponsored the research. The other authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study was approved by the ethics committee of the Technische Universit\u00e4t Dresden and was performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments. All participants (or their guardians, if under 18\u00a0years old) gave written informed consent prior to their inclusion in the study after full explanation of the purpose and nature of all procedures used.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}